About

About JIANGSU YAOHAI BIO-PHARMACEUTICAL Co. ,Ltd Yaohai Biopharmaceutical Co., Ltd. was founded in August 2010. It has served as a Microbial CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in microbial expression systems and offering one-stop services, including microbial strain engineering, microbial cell banking, process development, pilot scale-up, cGMP-guided manufacturing, fill and finish, analysis and testing, etc. Since its establishment, we have been focusing on “VLP vaccine, peptide, cytokine, nano-antibody, enzyme, plasmid DNA, mRNA, and others recombinant proteins or nucleic acids” as vaccines or therapeutics for human, veterinary, and pet health management. Yaohai Bio-Pharma, founded in August 2010, is a specialized Microbial CRDMO (Contract Research, Development, and Manufacturing Organization) offering end-to-end services based on microbial expression systems. Our integrated solutions span strain engineering, cell banking, process development, cGMP manufacturing, analytical testing, fill-finish, and regulatory support. We focus on recombinant protein/peptide, nano-body, mRNA, plasmid DNA, VLP vaccines and other modalities for both human and veterinary use. Core Strengths: 1. Comprehensive Service Platform: Covering the full development cycle—from preclinical to commercial production—under global regulatory standards (NMPA, FDA, EMA). 2. Advanced Manufacturing Capacity: 5 drug substance lines with a total microbial fermentation capacity of 7,500L (2L–2,000L), plus 2 drug product workshops for sterile fill-finish of vials (liquid/lyophilized powder) and pre-filled syringes/cartridges. 3. Scalable Solutions: Supporting rapid scale-up with GMP-compliant facilities and fermentors ranging from 2L to 2,000L. 4. Proven Expertise: A seasoned team with 15+ years of experience, delivering over 200 successful projects across diverse therapeutic areas.